Patients with SLE (n=18) | Healthy controls (n=15) | Patients with RA (n=8) | |
---|---|---|---|
Demographics | |||
Age (mean±SEM) | 37±3 | 38±4 | 49±4 |
Sex | Female | Female | Female |
SLEDAI (mean±SEM) | 6±1 | – | – |
Medications | |||
Azathioprine | 6% | – | – |
Etanercept | – | – | 25% |
Hydroxychloroquine | 67% | – | 63% |
Methotrexate | 11% | – | 75% |
Mycophenolate mofetil | 33% | – | – |
Prednisone | 61% | – | 50% |
Quinacrine | 17% | – | – |
Rituximab | – | – | 25% |
Sulfasalazine | – | – | 13% |
Tocilizumab | – | – | 13% |
RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SLEDAI, SLE disease activity index.